You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康哲藥業(00867.HK)與泰諾麥博成立合資及進行戰略合作
阿思達克 04-19 08:37
康哲藥業(00867.HK)公布,通過全資附屬公司與泰諾麥博達成一系列協議以進行戰略合作,並對泰諾麥博進行股權投資及與其成立合營公司,公司將持有泰諾麥博之6%股權。後者開發全人源抗金黃色葡萄球菌α毒素抗體新藥。

集團將與泰諾麥博成立合營公司,其中集團以現金出資,泰諾麥博將以包含其產品泰諾麥博全人源Hlα抗體在內的由相關協議約定的特定產品相關技術的大中華地區權益作為無形資產出資,集團與泰諾麥博將分別擁有合營公司50%權益。合營公司將委託集團負責所有合作產品在大中華地區的臨床開發及商業化工作,及將委託泰諾麥博負責所有合作產品的生產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account